Have a personal or library account? Click to login
Multidrug resistance by biofilm-forming clinical strains of Proteus mirabilis Cover

Multidrug resistance by biofilm-forming clinical strains of Proteus mirabilis

Open Access
|Jan 2017

Figures & Tables

Figure 1

Percentage of weak biofilm forming (WBF, 2 total), intermediate biofilm forming (IBF, 11 total), strong biofilm forming (SBF, 2 total) and all P. mirabilis strains (ALL) in various clinical materials.
Percentage of weak biofilm forming (WBF, 2 total), intermediate biofilm forming (IBF, 11 total), strong biofilm forming (SBF, 2 total) and all P. mirabilis strains (ALL) in various clinical materials.

Figure 2

Percentage of weak biofilm forming (WBF), intermediate biofilm forming (IBF), strong biofilm forming (SBF), and all P. mirabilis strains in different service units.(PE = pediatric emergency (5 total), EMD = endocrine and metabolic diseases (1 total), URO = urology (2 total), EM = emergency medicine (2 total), O = otorhinolaryngology (1 total), GS = general surgery (1 total), PED = pediatrics (3 total)
Percentage of weak biofilm forming (WBF), intermediate biofilm forming (IBF), strong biofilm forming (SBF), and all P. mirabilis strains in different service units.(PE = pediatric emergency (5 total), EMD = endocrine and metabolic diseases (1 total), URO = urology (2 total), EM = emergency medicine (2 total), O = otorhinolaryngology (1 total), GS = general surgery (1 total), PED = pediatrics (3 total)

Figure 3

Percentage of weak biofilm forming (WBF), intermediate biofilm forming (IBF), strong biofilm forming (SBF) and all P. mirabilis strains (ALL) in individuals of various ages. (16-30 y, 4 strains total; 46-60 y and 61-75 y 1 strain each)
Percentage of weak biofilm forming (WBF), intermediate biofilm forming (IBF), strong biofilm forming (SBF) and all P. mirabilis strains (ALL) in individuals of various ages. (16-30 y, 4 strains total; 46-60 y and 61-75 y 1 strain each)

Figure 4

Percentage of weak biofilm forming (WBF), intermediate biofilm forming (IBF), strong biofilm forming (SBF) and all P. mirabilis strains (ALL) displaying resistance to 15 different antibiotics in various classes of antibiotics (SXT = trimethoprim/sulfamethoxazole, AMC = amoxicillin/clavulanic acid, CFM = cefixime, CIP = ciprofloxacin, CC = clindamycin, AK = amikacin, CN = gentamicin, CAZ = cefazolin, NN = tobramycin, AM = ampicillin, CRO = ceftriaxone, CZ = ceftazidime, TZP = piperacillin/tazobactam, IPM = imipenem, F = nitrofurantoin)
Percentage of weak biofilm forming (WBF), intermediate biofilm forming (IBF), strong biofilm forming (SBF) and all P. mirabilis strains (ALL) displaying resistance to 15 different antibiotics in various classes of antibiotics (SXT = trimethoprim/sulfamethoxazole, AMC = amoxicillin/clavulanic acid, CFM = cefixime, CIP = ciprofloxacin, CC = clindamycin, AK = amikacin, CN = gentamicin, CAZ = cefazolin, NN = tobramycin, AM = ampicillin, CRO = ceftriaxone, CZ = ceftazidime, TZP = piperacillin/tazobactam, IPM = imipenem, F = nitrofurantoin)

0.1 ≤ OD < 0.4Weak Biofilm Former (WBF)
0.4 ≤ OD < 0.8Intermediate Biofilm Former (IBF)
OD ≥ 0.8Strong Biofilm Former (SBF)

Percentage of P_ mirabilis strains displaying resistance to 5 different classes of antibiotics and percentage of multidrug resistant P_ mirabilis strains in each biofilm group_

WBF P. mirabilis strains (%)IBF P. mirabilis strains (%)SBF P. mirabilis strains (%)
Multidrug resistance1/2 (50)7/11 (63)2/2 (100)
Resistance to 5 different classes of antibiotics02/11 (18)2/2 (100)
DOI: https://doi.org/10.5372/1905-7415.0904.424 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 535 - 541
Published on: Jan 31, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Gulcan Sahal, Isil Seyis Bilkay, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.